Predictor™ Compatible Microplate
Reader Documentation Version No.:
10 Mar 09 Page 1 of 11
Setup Guide on the Tecan Infinite® F500 Microplate Reader
Have a question? Contact our Technical Support Team
NA: 800-955-6288 or INTL: 760-603-7200 Select option 3, ext. 40266 Email: drugdiscoverytech@invitrogen.com
Predictor™ Assay Setup Guide on the
Tecan Infinite® F500 Microplate Reader
NOTE: The Tecan Infinite® F500 Microplate Reader was tested for compatibility with
Invitrogen's Predictor™ hERG FP Assay (PV5365) using controls provided within the assay kit
and the known hERG channel blockers astemizole and terfenadine. The following document is
intended to demonstrate setup of this instrument. For more detailed information and technical
support of Invitrogen assays please call 1-800-955-6288, select option "3", then extension
40266. For more detailed information and technical support of Tecan instruments or software,
please contact Tecan at 1-888-798-0538 or [email protected].
A. Recommended Optics
Tecan
part number wavelength (nm) diameter (mm)
Excitation Filter
*contact Tecan 535/25 12.5
Emission Filter 1
*contact Tecan 590/20
(S-pol) 12.5
Emission Filter 2
*contact Tecan 590/20
(P-pol) 12.5
Dichroic Mirror
*contact Tecan 560
(Cy3)
B. Instrument Setup
1. Make certain plate reader is turned on, and open up Tecan i-Control software
on computer.
Predictor™ Compatible Microplate
Reader Documentation Version No.:
10 Mar 09 Page 2 of 11
Setup Guide on the Tecan Infinite® F500 Microplate Reader
Have a question? Contact our Technical Support Team
NA: 800-955-6288 or INTL: 760-603-7200 Select option 3, ext. 40266 Email: drugdiscoverytech@invitrogen.com
3. At this point, a secondary settings window will open (below). Select the portino
of the plate you wish to read by dragging across with your mouse to highlight
selected wells, and in the new Fluorescence Polarization tab below, select your
excitation and emission settings and dichroic from the drop-down lists. Select
“Optimal” for the Gain, and select a well with tracer in it for Z-positions (well B2 in
this example). When finished, under “Measurement” select the “Change...” tab.
Predictor™ Compatible Microplate
Reader Documentation Version No.:
10 Mar 09 Page 3 of 11
Setup Guide on the Tecan Infinite® F500 Microplate Reader
Have a question? Contact our Technical Support Team
NA: 800-955-6288 or INTL: 760-603-7200 Select option 3, ext. 40266 Email: drugdiscoverytech@invitrogen.com
4. A new popup window will appear. Select your Measurement Blank Range wells,
in this case Column 16. When finished, select “OK”.
Predictor™ Compatible Microplate
Reader Documentation Version No.:
10 Mar 09 Page 4 of 11
Setup Guide on the Tecan Infinite® F500 Microplate Reader
Have a question? Contact our Technical Support Team
NA: 800-955-6288 or INTL: 760-603-7200 Select option 3, ext. 40266 Email: drugdiscoverytech@invitrogen.com
5. You will return to the main assay setup window. Under “G-Factor”, select the
“Calibrate” button, then select the “Change” tab.
Predictor™ Compatible Microplate
Reader Documentation Version No.:
10 Mar 09 Page 5 of 11
Setup Guide on the Tecan Infinite® F500 Microplate Reader
Have a question? Contact our Technical Support Team
NA: 800-955-6288 or INTL: 760-603-7200 Select option 3, ext. 40266 Email: drugdiscoverytech@invitrogen.com
6. Once again, a popup window will appear. Select the G-Factor Reference Range
(the Free Tracer wells in Column 15 in this case). Select “OK” when finished.
Predictor™ Compatible Microplate
Reader Documentation Version No.:
10 Mar 09 Page 6 of 11
Setup Guide on the Tecan Infinite® F500 Microplate Reader
Have a question? Contact our Technical Support Team
NA: 800-955-6288 or INTL: 760-603-7200 Select option 3, ext. 40266 Email: drugdiscoverytech@invitrogen.com
7. You will return to the main setup window a final time. Under “G-Factor” set the
Reference Value to 50mP to set the mP value for free tracer. When finished,
select “Start” from the toolbar at the top to begin reading your plate.
Predictor™ Compatible Microplate
Reader Documentation Version No.:
10 Mar 09 Page 7 of 11
Setup Guide on the Tecan Infinite® F500 Microplate Reader
Have a question? Contact our Technical Support Team
NA: 800-955-6288 or INTL: 760-603-7200 Select option 3, ext. 40266 Email: drugdiscoverytech@invitrogen.com
C. Predictor™ hERG FP Assay
NOTE: The following is a sample assay performed for demonstration purposes. The
instrument settings above would be sufficient for any Predictor™ assay or other
Invitrogen red FP assay, the information below is provided as representative data.
Assays were run in 20 µl in 384-well untreated low-volume polystyrene plates (Corning
#3677). In order to demonstrate the correction of Polarization Interference at high
concentrations of compound described in the Predictor protocol Section 4.5, we
prepared dose-response curves of both astemizole and terfenadine with and without
saturating E-4031. Also, all FP data was background-subtracted using wells containing
membranes but no tracer. Note background subtraction is not required, but is strongly
advised and can increase overall assay window by 10-20%.
1. Thaw all reagents as directed in protocol. Thaw compounds (Astemizole and
Terfenadine, 1 mM stocks in DMSO) at room temp.
2. Prepare Predictor™ hERG membrane by sonification, dounce homogenization, or
trituration to ensure a uniform suspension with no precipitate or aggregates.
3. A dilution series of both astemizole and terfenadine was prepared as follows:
3.1. 1:10 pre-dilution: In a 96-well plate, add 40 µl of DMSO to wells B1-H1
and A2-H2 (for Astemizole pre-dilution) and B7-H7 and A8-H8 (for
Terfenadine pre-dilution).
3.2. Add 40 µl of 1 mM astemizole to well A1 and 40 µl of 1 mM terfenadine to
well A7.
3.3. Prepare Master Dilutions: Transfer 20 µl from well A1 to well A2, mix by
pipetting up and down several times, then transfer 20 µl from well A2 to
well B1, mix again, then transfer 20 µl from well B1 mixed into well B2, mix
again, then transfer 20 µl from well B2 to well C1, repeating this pattern
downwards to the bottom of plate (see Figure 1). Repeat this same
procedure with terfenadine starting in well A7,
3.4. From well A1, remove 4 µl compound in DMSO and add to well A3 in
column 3. From well A2, remove 4 µl compound in DMSO and add to well
A4 in column 4. Repeat to bottom of plate, transferring 4 µl aliquots from
initial dilution to new column. This step can be simplified by use of a
multichannel pipette.
Predictor™ Compatible Microplate
Reader Documentation Version No.:
10 Mar 09 Page 8 of 11
Setup Guide on the Tecan Infinite® F500 Microplate Reader
Have a question? Contact our Technical Support Team
NA: 800-955-6288 or INTL: 760-603-7200 Select option 3, ext. 40266 Email: drugdiscoverytech@invitrogen.com
3.5. Repeat for terfenadine, adding 4 µl to columns 9 and 10. When finished,
add 96 µl Predictor™ hERG FP Assay Buffer to each new well to create
the intermediate dilution series.
4. Add 5 µl compound per well to a nontreated Corning 3677 black polystyrene 384-
well plate, as follows:
4.1. From well A3 of the 96-well plate (maximum astemizole, conc. 40 µM)
transfer 6 replicates of 5 µl compound to wells A1-A6 of the 384 assay
plate. In the end, column 3 of the 96-well plate will fill the first 6 wells in
rows A,C, E, G, I, K, M, and O while column 4 will fill the first 6 wells of
rows B, D, F, H, J, L, N, and P. Repeat same procedure was repeated for
the next 6 wells in each row on the 384-well assay plate using columns 9
and 10. This step can be simplified by use of a multichannel pipette.
Figure 1: Schematic for Preparation of Compound Dilution. Schematic
demonstrates progression of dilutions and final transfer to assay plate. Note in this
case 2 compounds were titrated and each compound was finally used in replicates
of 6 (3 with and 3 without saturating E-4031).
Column 3
Column 4
Column 3
Column 4
Column 1
Column 2
Master Dilutions
100X
(96-well plate)
Intermediate Dilutions
4X
(96-well plate)
Assay
Plate
(384-well plate)
Assay
Plate
(384-well plate)
Column 3
Column 4
Column 3
Column 4
Column 1
Column 2
Master Dilutions
100X
(96-well plate)
Intermediate Dilutions
4X
(96-well plate)
Assay
Plate
(384-well plate)
Assay
Plate
(384-well plate)
Predictor™ Compatible Microplate
Reader Documentation Version No.:
10 Mar 09 Page 9 of 11
Setup Guide on the Tecan Infinite® F500 Microplate Reader
Have a question? Contact our Technical Support Team
NA: 800-955-6288 or INTL: 760-603-7200 Select option 3, ext. 40266 Email: drugdiscoverytech@invitrogen.com
5. Once compound titration wells are prepared (columns 1-12 of assay plate), also
prepare the following controls:
• Negative Control, Tracer fully Bound (Column 13, B). Add 5 ul
Predictor™ buffer containing 4% DMSO to all wells in Column 13 (to
control for DMSO in titration wells). Tracer and membrane will be added
later. This control will show full tracer binding activity of assay.
• Positive control, Tracer Displaced (Column 14, D). Add 8 µl E-4031
to 192 µl Predictor™ hERG FP Assay Buffer also containing 4% DMSO.
Add 5 µl per well of this solution to each well of Column 14 of assay plate.
Tracer and membrane will be added later. This control will show
maximum displacement of tracer from the hERG channels in the
membrane prep.
• Free Tracer Control (Column 15, F). Add 15 µl Predictor™ hERG FP
Assay Buffer to each well of column 15. Tracer will be added later. This
control will show fully unbound tracer in solution, as well as being used to
calibrate the instrument.
• Assay Blank (Column 16, Blank). Add 10 µl of Predictor™ hERG FP
Assay Buffer per well to Column 16. 10 µl membrane will be added later.
This control will show background fluorescence and to background
subtract the rest of the assay wells prior to calculating FP values.
6. Sonicated/triturated membrane split: remove 2 ml Predictor membrane and add
40 µl E-4031 to these membranes.
7. Add 10 µl E-4031-containing membrane per well to columns 4-6 (astemizole with
E-4031 baseline subtraction) and 10-12 (terfenadine with E-4031 baseline
subtraction).
8. Add 10 µl untreated membrane per well to columns 1-3 (astemizole), 7-9
(terfenadine), 13 (Bound Tracer), 14 (Displaced Tracer), and 16 (Blank).
9. Tracer added last: Add 32 µl tracer to 1968 µl Predictor hERG FP Assay Buffer
and add 5 µl/well of this solution to all wells in Columns 1-15.
NOTE: Predictor™ is a highly sensitive assay. Furthermore, the baseline correction
wells use saturating levels of E-4031. It is extremely important to ensure that
pipetting steps are done carefully and there is no carryover/contamination
of neighboring wells in Predictor. The order of wells in the plate layout may
be changed to best facilitate your pipetting and minimizing carryover if desired,
but all the controls above are highly recommended.
Predictor™ Compatible Microplate
Reader Documentation Version No.:
10 Mar 09 Page 10 of 11
Setup Guide on the Tecan Infinite® F500 Microplate Reader
Have a question? Contact our Technical Support Team
NA: 800-955-6288 or INTL: 760-603-7200 Select option 3, ext. 40266 Email: drugdiscoverytech@invitrogen.com
10. Shake plate on an orbital plate shaker for 30 seconds, cover with foil, and
incubate 2 hours before reading.
11. Read plate on plate reader as outlined above.
Figure 2: Schematic of Assay Plate Layout. Predictor™ hERG assay was set up
with a dose-response curve of Astemizole and Terfenadine (1:3 dilution series from
a starting concentration in the top row of 10 µM) prepared in replicates of 6. From
this, 3 replicates were assayed for ability to disrupt Predictor™ Tracer binding and 3
were assayed in saturating levels of E-4031 in order to prepare a baseline correction
for each data point.
Astemizole A + E-4031 Terfenadine T + E-4031 B D F
B
lank
123456789101112131415161718192021222324
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Predictor™ Compatible Microplate
Reader Documentation Version No.:
10 Mar 09 Page 11 of 11
Setup Guide on the Tecan Infinite® F500 Microplate Reader
Have a question? Contact our Technical Support Team
NA: 800-955-6288 or INTL: 760-603-7200 Select option 3, ext. 40266 Email: drugdiscoverytech@invitrogen.com
D. Results:
Figure 3: Predictor™ hERG FP Assay. Dose-Response Curves read on the Tecan
Infinite® F500 using the Predictor™ assay and 1:3 dilution series prepared for
Astemizole and Terfenadine from a starting concentration of 10 µM. Curve calculations
were baseline-corrected against duplicate dilution series prepared in saturating E-4031.
avg std dev
free tracer 54.13 4.05
no inhibitor 312.85 8.65
30 uM E-4031 159.13 3.04
ΔmP 153.72
Z'-factor 0.77
Astemizole IC50 1.79 nM
Terfenadine IC50 11.78 nM
Table 1. Predictor™ Assay Results on the Tecan Infinite® F500.
Predictor
TM
hERG Assay
-4 -3 -2 -1 0 1 2 3 4 5
100
150
200
250
300
350
Astemizole
Terfenadine
log [compound] (nM)
polarization (mP)
/
